Selected articles
Articles for label Navrátil Jiří are displayed.. Show all articles
Patient with metastatic renal cell carcinoma, who was treated with tyrosine kinase inhibitor in first and second line of palliative treatment
04/2020 MUDr. Jiří Navrátil, Ph.D.
Disseminated renal cancer is an incurable disease. The fundamental of treatment is targeted therapy with tyrosine kinase inhibitors (TKI). We present a case report of a polymorbid patient with disseminated renal clear cell carcinoma treated with two lines of TKI with a good response to treatment while a good quality of life.
ENTIRE ARTICLE
Disseminated renal cancer is an incurable disease. The fundamental of treatment is targeted therapy with tyrosine kinase inhibitors (TKI). We present a case report of a polymorbid patient with disseminated renal clear cell carcinoma treated with two lines of TKI with a good response to treatment while a good quality of life.
Adverse events of oncological treatment in a general practitioner’s ambulance
05/2019 MUDr. Jiří Navrátil, Ph.D.
Cancer treatment may be accompanied by a number of side effects. We always try to educate our patients, they are equipped with a telephone emergency number and often also with rescue medication, which they can use in case of problems (antiemetics, antidiarrheals, analgesics, etc.). Nevertheless, there may be situations where patients go with their problems primarily to a general practitioner (they do not use the recommended medication, or the recommended medication is not enough, the patient did not pick up the drugs in the pharmacy and so on). Good cooperation between a general practitioner and an oncologist is therefore very important. The most common side effects of oncological treatment including immunotherapy and their management in general practitioner will be presented in the article.
ENTIRE ARTICLE
Cancer treatment may be accompanied by a number of side effects. We always try to educate our patients, they are equipped with a telephone emergency number and often also with rescue medication, which they can use in case of problems (antiemetics, antidiarrheals, analgesics, etc.). Nevertheless, there may be situations where patients go with their problems primarily to a general practitioner (they do not use the recommended medication, or the recommended medication is not enough, the patient did not pick up the drugs in the pharmacy and so on). Good cooperation between a general practitioner and an oncologist is therefore very important. The most common side effects of oncological treatment including immunotherapy and their management in general practitioner will be presented in the article.